Last year was a pivotal year for the pharmaceutical industry. Under the IRA’s Medicare Drug Price Negotiation Program (the ...

We spoke recently with Craig Burton, MBA, executive director of the Biosimilars Council, a trade and lobbying group for the ...

Shares of Equillium (NASDAQ:EQ) soared 26% Thursday after the company and partner Biocon reported positive topline results from a Phase 2 study of the drug itolizumab in the treatment of moderate to ...

The second part of our conversation with Craig Burton, MBA, executive director of the Biosimilars Council, a trade and ...

Organon (NYSE: OGN) today announced its results for the fourth quarter and full year ended December 31, 2024. “In 2024 we achieved our third year of constant currency revenue growth and delivered ...

Prescription drugs are used to target specific pro- and anti-inflammatory cytokines. Adalimumab (brand names Humira, Amgevita, Hyrimoz, Idacio, Imraldi, and Yuflyma), which is used to treat conditions ...

The global wellness economy surpassing $7 trillion signals a cultural shift, where brands that champion innovation, ...

It can take months or years for your target audience to recognize your brand name and even longer for people to pronounce it. I speak from experience. When we launched the unique combination of ...

Your brand's ability and willingness to solve pain points for current and potential customers can make or break your company's existence and relevance in the industry. To help brand leaders remain ...

One of the cheapest companies I have come across recently is none other than ACCO Brands Corporation (NYSE:ACCO), a diversified provider of consumer, technology, and branded business products.

In working with these clients and helping them create narratives that stick, I’ve learned the key to successful brand storytelling isn’t necessarily about relying on your company’s name from ...